These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38244380)

  • 1. Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: In silico, in vitro, and in vivo evaluations.
    Azmi A; Noori M; Khalili Ghomi M; Nazari Montazer M; Iraji A; Dastyafteh N; Oliyaei N; Khoramjouy M; Rezaei Z; Javanshir S; Mojtabavi S; Faramarzi MA; Asadi M; Faizi M; Mahdavi M
    Bioorg Chem; 2024 Mar; 144():107106. PubMed ID: 38244380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties.
    Khalili Ghomi M; Noori M; Mirahmad M; Iraji A; Sadr AS; Dastyafteh N; Asili P; Gholami M; Javanshir S; Lotfi M; Mojtabavi S; Faramarzi MA; Asadi M; Nasli-Esfahani E; Palimi M; Larijani B; Meshkatalsadat MH; Mahdavi M
    Eur J Med Chem; 2024 Apr; 269():116332. PubMed ID: 38508120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.
    Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.
    Moghadam Farid S; Noori M; Nazari Montazer M; Khalili Ghomi M; Mollazadeh M; Dastyafteh N; Irajie C; Zomorodian K; Mirfazli SS; Mojtabavi S; Faramarzi MA; Larijani B; Iraji A; Mahdavi M
    Sci Rep; 2023 Mar; 13(1):4392. PubMed ID: 36928433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors.
    Noori M; Davoodi A; Iraji A; Dastyafteh N; Khalili M; Asadi M; Mohammadi Khanaposhtani M; Mojtabavi S; Dianatpour M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2022 Aug; 12(1):14019. PubMed ID: 35982225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors.
    Forozan R; Ghomi MK; Iraji A; Montazer MN; Noori M; Dastyafteh N; Mojtabavi S; Faramarzi MA; Sadat-Ebrahimi SE; Larijani B; Javanshir S; Mahdavi M
    Sci Rep; 2023 May; 13(1):7819. PubMed ID: 37188744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations.
    Wang KM; Ge YX; Zhang J; Chen YT; Zhang NY; Gu JS; Fang L; Zhang XL; Zhang J; Jiang CS
    Bioorg Med Chem Lett; 2023 Jan; 79():129069. PubMed ID: 36395995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Glucosidase inhibitory effect of resveratrol and piceatannol.
    Zhang AJ; Rimando AM; Mizuno CS; Mathews ST
    J Nutr Biochem; 2017 Sep; 47():86-93. PubMed ID: 28570943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 4-thiosubstituted flavan derivatives and their hypoglycemic activities.
    Zhang X; Yun JP; Yang YN; Feng ZM; Jiang JS; Yuan X; Liu W; Zhang PC
    Fitoterapia; 2022 Sep; 161():105255. PubMed ID: 35907488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes.
    Chaidam S; Saehlim N; Athipornchai A; Sirion U; Saeeng R
    Bioorg Med Chem Lett; 2021 Oct; 50():128331. PubMed ID: 34418573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.